These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 15580566)
1. Molecular and muscle pathology in a series of caveolinopathy patients. Fulizio L; Nascimbeni AC; Fanin M; Piluso G; Politano L; Nigro V; Angelini C Hum Mutat; 2005 Jan; 25(1):82-9. PubMed ID: 15580566 [TBL] [Abstract][Full Text] [Related]
2. Caveolin-3 deficiency associated with the dystrophy P104L mutation impairs skeletal muscle mitochondrial form and function. Shah DS; Nisr RB; Stretton C; Krasteva-Christ G; Hundal HS J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):838-858. PubMed ID: 32090499 [TBL] [Abstract][Full Text] [Related]
3. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex. Galbiati F; Volonte D; Minetti C; Chu JB; Lisanti MP J Biol Chem; 1999 Sep; 274(36):25632-41. PubMed ID: 10464299 [TBL] [Abstract][Full Text] [Related]
4. Caveolinopathies in Greece. Papadopoulos C; Papadimas GK; Kekou K; Spengos K; Svigou M; Kitsiou-Tzeli S; Manta P Neurologist; 2015 Jul; 20(1):8-12. PubMed ID: 26185955 [TBL] [Abstract][Full Text] [Related]
5. Biochemical and pathological changes result from mutated Caveolin-3 in muscle. González Coraspe JA; Weis J; Anderson ME; Münchberg U; Lorenz K; Buchkremer S; Carr S; Zahedi RP; Brauers E; Michels H; Sunada Y; Lochmüller H; Campbell KP; Freier E; Hathazi D; Roos A Skelet Muscle; 2018 Aug; 8(1):28. PubMed ID: 30153853 [TBL] [Abstract][Full Text] [Related]
6. Two novel CAV3 gene mutations in Japanese families. Sugie K; Murayama K; Noguchi S; Murakami N; Mochizuki M; Hayashi YK; Nonaka I; Nishino I Neuromuscul Disord; 2004 Dec; 14(12):810-4. PubMed ID: 15564037 [TBL] [Abstract][Full Text] [Related]
7. CAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: Expanding the phenotypic spectrum of caveolinopathies. Scalco RS; Gardiner AR; Pitceathly RD; Hilton-Jones D; Schapira AH; Turner C; Parton M; Desikan M; Barresi R; Marsh J; Manzur AY; Childs AM; Feng L; Murphy E; Lamont PJ; Ravenscroft G; Wallefeld W; Davis MR; Laing NG; Holton JL; Fialho D; Bushby K; Hanna MG; Phadke R; Jungbluth H; Houlden H; Quinlivan R Neuromuscul Disord; 2016 Aug; 26(8):504-10. PubMed ID: 27312022 [TBL] [Abstract][Full Text] [Related]
8. Novel splice site mutation in the caveolin-3 gene leading to autosomal recessive limb girdle muscular dystrophy. Müller JS; Piko H; Schoser BG; Schlotter-Weigel B; Reilich P; Gürster S; Born C; Karcagi V; Pongratz D; Lochmüller H; Walter MC Neuromuscul Disord; 2006 Jul; 16(7):432-6. PubMed ID: 16730439 [TBL] [Abstract][Full Text] [Related]
9. The caveolin-3 P104L mutation in LGMD-1C patients inhibits non-insulin-stimulated glucose metabolism and growth but promotes myocyte proliferation. Shang L; Chen T; Xian J; Deng Y; Huang Y; Zhao Q; Liang G; Liang Z; Lian F; Wei H; Huang Q Cell Biol Int; 2019 Jun; 43(6):669-677. PubMed ID: 30958599 [TBL] [Abstract][Full Text] [Related]
10. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency. Minetti C; Bado M; Broda P; Sotgia F; Bruno C; Galbiati F; Volonte D; Lucania G; Pavan A; Bonilla E; Lisanti MP; Cordone G Am J Pathol; 2002 Jan; 160(1):265-70. PubMed ID: 11786420 [TBL] [Abstract][Full Text] [Related]
15. Caveolinopathies: from the biology of caveolin-3 to human diseases. Gazzerro E; Sotgia F; Bruno C; Lisanti MP; Minetti C Eur J Hum Genet; 2010 Feb; 18(2):137-45. PubMed ID: 19584897 [TBL] [Abstract][Full Text] [Related]
16. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes. Smythe GM; Eby JC; Disatnik MH; Rando TA J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260 [TBL] [Abstract][Full Text] [Related]
18. Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro. Traverso M; Gazzerro E; Assereto S; Sotgia F; Biancheri R; Stringara S; Giberti L; Pedemonte M; Wang X; Scapolan S; Pasquini E; Donati MA; Zara F; Lisanti MP; Bruno C; Minetti C Lab Invest; 2008 Mar; 88(3):275-83. PubMed ID: 18253147 [TBL] [Abstract][Full Text] [Related]
19. Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes. Fanin M; Nascimbeni AC; Aurino S; Tasca E; Pegoraro E; Nigro V; Angelini C Neurology; 2009 Apr; 72(16):1432-5. PubMed ID: 19380703 [TBL] [Abstract][Full Text] [Related]
20. Caveolinopathies: translational implications of caveolin-3 in skeletal and cardiac muscle disorders. Gazzerro E; Bonetto A; Minetti C Handb Clin Neurol; 2011; 101():135-42. PubMed ID: 21496630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]